Malta
Veracyte Inc (VCYT) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strong Test Performance
Total Revenue: Reached $96.8 million in Q1 2024, up 17% year-over-year, surpassing estimates of $93.37 million.Net Loss: Improved significantly to $1.9 million
Related
Share this page
Guest Posts by Easy Branches